Note 6 - Convertible Promissory Note Due to Novartis - Convertible Debt (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Convertible promissory note, opening balance | $ 1,350 | $ 1,300 |
| Convertible promissory note, ending balance | 1,350 | |
| Convertible Promissory Note Due to Novartis [Member] | ||
| Convertible promissory note, opening balance | 1,350 | |
| Less debt discount, opening | 0 | 0 |
| Plus, accretion of debt discount, interest expense | 0 | 0 |
| Convertible promissory note, net of discount | 1,350 | 1,300 |
| Interest accretion, opening | 0 | 0 |
| Interest accrual, expense | 50 | 50 |
| Convertible promissory note, ending balance | $ 1,400 | $ 1,350 |
| X | ||||||||||
- Definition Amount, after accumulated amortization, of debt discount. No definition available.
|
| X | ||||||||||
- Definition Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Increase for accrued, but unpaid interest on the debt instrument for the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|